The statistical analyses of tumor volumes showed that GSTO1‐KO significantly sensitized tumor cells to cisplatin treatment compared to parental cells (Fig. 7A), whereas GSTO1‐OE dramatically abolished the efficacy of cisplatin in tumor control (Fig. 7B). Here, GSTO1 is linked to neoplasm.